In typical cavalier fashion, drug giant Purdue Pharma has decided to curtail the sale of OxyContin that has brought misery and death to tens of thousands addicted to opioids.
Why it has taken so long for this scandal to end – particularly to families who have lost loved ones – is difficult to fathom. Perhaps, the allure of bonuses for licensed drug peddlers or the irresistible pull of a higher ...
Continue Reading →